Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-12-26

Clinical Trial Update: Clinical Trial of Rybelsus (Semaglutide) Among Adults With Alcohol Use Disorder (AUD) [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating semaglutide (Rybelsus) for alcohol use disorder has completed, with the trial conducted by the University of Colorado, Denver.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Rybelsus (semaglutide)

Snippet

Sponsor: University of Colorado, Denver | Conditions: Alcohol Use Disorder | Phase 2 | Status: COMPLETED